English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Nowadays, a laparoscopic surgery (LS) has become the cornerstone of the minimally invasive surgery in gynecology not only for benign diseases but also for malignant diseases. It has such tempting merits that most surgeons are not able to resist its attractions. Comparing with open surgery (OS), the established benefits of LS include incomparably much less postoperative pain thanks to tiny wound, shorter hospital stays and subsequent medical cost decrease, less estimated blood loss (EBL) and reducing possibility of transfusion with less postoperative complications and comparable treatment outcomes including survivals in selected cases. It has been found that laparoscopic pelvic lymphadenectomy was facilitated by the positive intraperitoneal pressure secondary to pneumoperitoneum, which helps dissect the pelvic spaces. 1 To date, with/without pelvic or para-aortic lymphadenectomy, laparoscopic radical hysterectomy for early stage cervical cancers and staging operation including total laparoscopic hysterectomy (TLH) or laparoscopic-assisted vaginal hysterectomy (LAVH) for endometrial cancers are widely performed by gynecologic oncologists in many centers across the globe. 2

Laparoscopic surgery is a current tide of widely accepted standard procedure for endometrial cancer